|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||||
| Current Assets: | |||||||||||||||||
| Cash | |||||||||||||||||
| Prepaid expenses | |||||||||||||||||
| Total Current Assets | |||||||||||||||||
| Cash and investments held in trust account | |||||||||||||||||
| Total Assets | |||||||||||||||||
| LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT | |||||||||||||||||
| Current Liabilities: | |||||||||||||||||
| Accounts payable and accrued expenses | |||||||||||||||||
| Note payable - sponsor; at fair value (cost $1,100,000) | |||||||||||||||||
| Note payable - sponsor; at fair value (cost $1,975,000) | |||||||||||||||||
| Note payable - third party, at fair value (cost $200,000) | |||||||||||||||||
| Accrued offering costs | |||||||||||||||||
| Convertible promissory note payable – former sponsor | |||||||||||||||||
| Sponsor | |||||||||||||||||
| Third party | |||||||||||||||||
| Former sponsor | |||||||||||||||||
| Current sponsors | |||||||||||||||||
| Total convertible promissory note payable – former sponsor | |||||||||||||||||
| Due to related party | |||||||||||||||||
| Advances from related party | |||||||||||||||||
| Note payable - third party; at cost | |||||||||||||||||
| Third party | |||||||||||||||||
| Total note payable - third party; at cost | |||||||||||||||||
| Convertible promissory note payable - sponsor; at fair value (cost $2,745,000 as of March 31, 2024 and $2,235,000 as of December 31, 2023, respectively) | |||||||||||||||||
| Related Parties | |||||||||||||||||
| Total convertible promissory note payable - sponsor; at fair value (cost $2,745,000 as of March 31, 2024 and $2,235,000 as of December 31, 2023, respectively) | |||||||||||||||||
| Convertible promissory note payable - third party; at fair value (cost nil as of March 31, 2024 and $310,000 as of December 31, 2023, respectively) | |||||||||||||||||
| Convertible promissory note payable – current sponsors | |||||||||||||||||
| Total Current Liabilities | |||||||||||||||||
| Derivative warrant liabilities | |||||||||||||||||
| Deferred underwriting commission | |||||||||||||||||
| Total Liabilities | |||||||||||||||||
| Class A ordinary shares subject to possible redemption; 489,887 shares (at redemption value of $13.19 and $12.95 at March 31, 2026 and December 31, 2025, respectively) | |||||||||||||||||
| Class A | |||||||||||||||||
| Class A ordinary shares subject to possible redemption | |||||||||||||||||
| Total class A ordinary shares subject to possible redemption; 489,887 shares (at redemption value of $13.19 and $12.95 at March 31, 2026 and December 31, 2025, respectively) | |||||||||||||||||
| Shareholders' deficit: | |||||||||||||||||
| Ordinary shares | |||||||||||||||||
| Class A | |||||||||||||||||
| Class A ordinary not subject to possible redemption | |||||||||||||||||
| Total class A | |||||||||||||||||
| Class B | |||||||||||||||||
| Accumulated deficit | |||||||||||||||||
| Total Shareholders' Deficit | |||||||||||||||||
| LIABILITIES, ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS' DEFICIT | |||||||||||||||||
Loading...
